Onkure Therapeutics, Inc. · NASDAQ:OKUR

Citadel Advisors LLC's stake in Onkure Therapeutics, Inc. fell to 1.70% (Schedule 13G/A)

Event Dec 31, 2025 · Filed Feb 17, 2026

Citadel Advisors LLC's stake in Onkure Therapeutics, Inc. fell to 1.70%, 223,125 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G/A).

Stake
1.70%
Shares
223,125
Intent
Passive
What changed
Fell below 5%
Filed together
7 holders

The filing in full

HolderStakeShares
Citadel Advisors LLC0.40%48,957
Citadel Advisors Holdings LP0.40%48,957
Citadel GP LLC0.40%48,957
Citadel Securities LLC1.40%174,168
Citadel Securities Group LP1.40%174,168
Citadel Securities GP LLC1.40%174,168
Kenneth Griffin1.70%223,125

Source

View original at SEC

Related